undamentalytics Newsletter

Mimedx Group vs Sintx Technologies

Mimedx Group is the larger business, with $419m of revenue in fiscal 2025 against $1.0m for Sintx Technologies (411.2 times as much). Mimedx Group grew faster (20.0% against -64.7%). Mimedx Group kept more of each dollar of sales as profit: a net margin of 11.6% against -1018.1%.

Latest fiscal yearMimedx GroupMDXG, 2025Sintx TechnologiesSINT, 2025
Revenue $419m $1.0m
Revenue growth 20.0% -64.7%
Net income $48.6m −$10.4m
Operating margin — -1053.1%
Net margin 11.6% -1018.1%
Return on equity 21.6% —
Free cash flow $74.0m −$8.8m
Cash $166m $4.1m
Total debt $18.0m $7,000
Debt to equity — 0.2%
Dividend per share — —
Dividend yield — —
Share buybacks $0 $133,000
Employees 808 32
Market value $462m $11.3m
Price vs our value range Below our value range —
Moat score 59 (Moderate) 22 (Weak)
Insider trades, 12 months 0 buys, 0 sales 17 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.